Real Estate Archives - Page 24 of 25

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

September 17, 2025

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

September 11, 2025

THIS WEEK'S STORIES

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

September 15, 2025

ConcertAI Appoints Casey Graves as General Manager of Clinical Solutions

September 11, 2025

Flavia Pease to Become Chief Financial Officer of Insulet

September 16, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Real Estate

Paysign Expands Patient Affordability Business with New 30,000 Square Foot Support Center

C2N Diagnostics Expands St. Louis Headquarters to Support Global Demand for Alzheimer’s Testing

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Facility

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, Massachusetts

Treasury Guidance Extends ITC Window, Safeguards Smaller Solar Projects, Says Solect Energy

Most Read

New Study Shows Masimo Continuous Monitoring Reduces Costs While Improving Patient Outcomes

Southlake Health Adopts Philips AI-Enabled MRI to Expand Diagnostic Imaging Capacity and Improve Patient Experience

Mongoose Software Launches from Stealth with Backing from Vertical Venture Partners to Redefine Digital Health Experiences

Synthesize Bio Launches with $10 Million Seed Round to Advance Generative Genomics

EDITOR PICKS

Vyome Reports Strong Preclinical Data Showing Topical VT-1908 Effective in Treating Uveitis, Targeting $3 Billion Market Opportunity

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

Takeda Appoints Rhonda Pacheco to Lead U.S. Business Unit as Julie Kim Prepares for CEO Role

THIS WEEK'S STORIES

Viridian Therapeutics Completes Enrollment in REVEAL Clinical Trials, Advances Portfolio

ConcertAI Appoints Casey Graves as General Manager of Clinical Solutions

Flavia Pease to Become Chief Financial Officer of Insulet

POPULAR CATEGORY

ABOUT US

FOLLOW US